Concepedia

M. Guarnieri

MG

Statistics

Publications

3

Citations

128

H-Index

3

Active since

2004

Affiliations

Novartis (United States)(Current)

Novartis (Switzerland)

M. Guarnieri is an author at Novartis (United States) specializing in medicine, parkinson disease, and neuroscience.

Top concepts

Publications per year

2004–2009

3

Publications

3

An open-label evaluation of the tolerability and safety of Stalevo� (carbidopa, levodopa and entacapone) in Parkinson?s disease patients experiencing wearing-off

William C. Koller, M. Guarnieri, Jean Hubble et al. · Journal of Neural Transmission · 2004 · 50 citations

, , +3

Pharmacokinetic‐pharmacodynamic crossover comparison of two levodopa extension strategies

Peter A. LeWitt, Danna Jennings, Kelly E. Lyons et al. · Movement Disorders · 2009 · 47 citations

The effect of entacapone on homocysteine levels in Parkinson disease

Jill L. Ostrem, Guolian Kang, Indu Subramanian et al. · Neurology · 2005 · 31 citations

, , +9

1–3 of 3